Latest Lead News

Kuniko Limited has made steady progress in developing its Norwegian battery metals projects, securing refinancing and preparing a rights issue to fund its next growth phase. Key partnerships and innovative exploration technologies underpin its strategic repositioning.

Altamin Limited progresses its innovative Lazio lithium and sulphate of potash project with key engineering studies underway, while its Gorno base metals project reports exceptional zinc, lead, and silver assay results, setting the stage for strategic partnership discussions.

Evolution Energy Minerals advances its development-ready Chilalo Graphite Project in Tanzania, targeting a Final Investment Decision by mid-2026 while exploring promising copper prospects and strengthening its leadership team.

4DMedical reports a 56% revenue surge in FY25 alongside a strategic $10 million investment from Pro Medicus, advancing its CT, VQ™ lung imaging technology towards FDA clearance.

Larvotto Resources delivers a robust Definitive Feasibility Study for its Hillgrove Antimony-Gold Project, backed by $165 million in fresh funding and regulatory approvals, targeting production in Q2 2026.

BOA Resources advances drilling plans for key lithium and nickel tenements in Western Australia despite delays in heritage and environmental approvals, while actively reviewing its asset portfolio amid IGO's exit from Symons Hill.

AVADA Group Limited reported a strong quarter with positive operating cash flows and significant debt reduction, while initiating a strategic review of its New Zealand operations amid challenging market conditions.

RocketBoots Limited has expanded its sales pipeline with five new customers covering over 8,550 locations and secured a strategic $1 million investment from Bombora Funds, positioning itself strongly in the growing AI retail technology market.

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.